Arformoterol Tartrate

The tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
01220042016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE Chronic obstructive pulmonary disease (COPD) is a progressive disease that impairs both objectively measured lung… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2014
2014
BACKGROUND Arformoterol tartrate (arformoterol, 15 μg bid) is a nebulized long-acting β2-agonist approved for maintenance… (More)
  • figure 1
  • figure 2
  • table 1
  • table 1
  • figure 3
Is this relevant?
2013
2013
BACKGROUND Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Review
2010
Review
2010
Some basic scientific data suggest that (S)-enantiomers of beta(2)-agonists have different and sometimes opposing effects to (R… (More)
  • figure 1
  • table 1
Is this relevant?
2009
2009
Arformoterol tartrate is a newly developed long-acting ssβ2-agonist with both acute and prolonged bronchodilator effects. It is… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2009
2009
Arformoterol tartrate inhalational solution is a nebulized bronchodilator that has been approved for long-term, twice-daily… (More)
Is this relevant?
2008
2008
BACKGROUND Arformoterol is a single-isomer (R,R-formoterol) nebulized long-acting beta(2)-agonist approved for use in patients… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
OBJECTIVE Arformoterol tartrate inhalation solution (15 microg/2 mL) is approved for the twice-daily, long-term maintenance… (More)
Is this relevant?
2007
2007
OBJECTIVE The aim of this study was to assess the efficacy and tolerability of nebulized arformoterol tartrate (a selective, long… (More)
Is this relevant?
Review
2004
Review
2004
  • Drugs in R&D
  • 2004
Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist… (More)
Is this relevant?